The cyclical revival of psychedelics in psychiatric treatment.

There is an increasing demand for effective treatments for depression, particularly for individuals grappling with treatment-resistant depression. Over recent years, a surge of interest has focused on exploring the safety and efficacy of psilocybin as a potential treatment for depression. However, preliminary findings from phase 2 studies have been inconclusive, prompting critical examination of issues such as maintaining blinding and the role of adjunctive psychotherapy. The maintenance of double-blinding and the role of adjunctive psychotherapy introduce biases that complicate the attainment of conclusive results in clinical research. Examining historical data reveals a recurrent pattern linked to the use of psychoactive substances, which starts with an excess of optimism and ends with general addictive behaviors and a heightened risk of serious public health problems. Considering these findings, a cautious and measured approach is imperative, given that the efficacy and safety of psilocybin treatment have yet to be unequivocally established. The potential for excessive optimism among researchers is a notable concern, as unwarranted enthusiasm may inadvertently facilitate the widespread adoption of this treatment without sufficient empirical support. In navigating the complexities of depression treatment, it is necessary to strike a balance between innovation and prudence to ensure evidence-based advancement of therapeutic approaches.

Prevalence of stress, burnout syndrome, anxiety and depression among physicians of a teaching hospital during the COVID-19 pandemic. / Prevalencia de estrés, síndrome de desgaste profesional, ansiedad y depresión en médicos de un hospital universitario durante la pandemia de COVID-19.

INTRODUCTION: Health care workers experience a tremendous strain while performing their activities, very frequently leading to stress, burnout syndrome, and psychopathological impact. The COVID-19 pandemic may cause physicians to suffer these effects even to a greater extent. Our objective was to describe the frequency of stress, burnout syndrome, anxiety, and depression during the pandemic, and analyze the associations with different independent outcome measures. METHODS: Observational, cross-sectional study conducted 2 months after the lockdown was established in Argentina. Clinical specialists, surgeons, emergency physicians, and those with no direct contact with patients were surveyed using a sociodemographic questionnaire and 3 self-administered inventories: Health Professions Stress Inventory, Maslach Burnout Inventory, and Hospital Anxiety and Depression Scale. RESULTS: The prevalence of stress was 93.7 % (95 % confidence interval [CI]: 90.33-96.2), burnout syndrome 73.5 % (95 % CI: 68.2-78.4), anxiety 44 % (95 % CI: 38.4-49.8), and depression 21.9 % (95 % CI: 17.3-26.9). No association was observed between the frequency and medical specialty. The frequency of burnout syndrome, anxiety, and depression was significantly higher among residents and physicians working in the emergency department. CONCLUSIONS: Residents and emergency physicians working 24-hour shifts showed significantly higher percentages of burnout syndrome, anxiety, and depression compared to staff and head physicians. These findings may be associated with a higher workload and less experience. It is compulsory to take preventive and therapeutic measures to protect those in the pandemic front line.

Introducción. Los trabajadores de la salud se encuentran sometidos a una gran tensión en el desarrollo de sus actividades, lo que genera alta frecuencia de estrés, desgaste laboral e impacto psicopatológico. La pandemia de COVID-19 podría provocar un incremento de estas entidades en los médicos. El objetivo fue describir la frecuencia de estrés, síndrome de desgaste profesional (burnout), ansiedad y depresión durante la pandemia, y analizar las asociaciones con distintas variables independientes. Métodos. Estudio observacional, transversal, realizado dos meses después del inicio de la cuarentena en Argentina. Se encuestó a médicos de especialidades clínicas, quirúrgicas, solo de emergencias, y a aquellos sin contacto directo con pacientes, mediante un cuestionario sociodemográfico y tres inventarios autoadministrados: Health Professions Stress Inventory, Maslach Burnout Inventory y la Escala de ansiedad y depresión hospitalaria. Resultados. La prevalencia de estrés fue del 93,7 % (IC95 %: 90,33-96,2), burnout 73,5 % (IC95 %: 68,2-78,4), ansiedad 44 % (IC95 %: 38,4- 49,8) y depresión 21,9 % (IC95 %: 17,3-26,9). No se observó asociación entre la frecuencia y el tipo de especialidad realizada. La frecuencia de burnout, ansiedad y depresión fue significativamente mayor en los médicos residentes y en aquellos que trabajan en emergencias. Conclusiones. Los médicos residentes y quienes trabajan en emergencias en turnos de 24 horas mostraron porcentajes significativamente más altos de burnout, ansiedad y depresión, en comparación con médicos de planta y con aquellos en posiciones de liderazgo. Estos hallazgos pueden estar asociados con una mayor carga de trabajo y una menor experiencia. Es mandatorio tomar medidas preventivas y terapéuticas para preservar a quienes hacen frente a esta pandemia. Palabras clave: COVID-19.

Medical cannabis: Risks related to its indication prior to approval. / Cannabis medicinal: riesgos relacionados con la indicación previa a su aprobación.

In recent years, the interest in medical cannabis prescription has increased significantly. This article provides information about the little scientific basis supporting the prescription of these products for a wide and diverse range of medical conditions. It is critical for any substance to be used in human beings to follow a strict scientific approval protocol, detached from any trend or individual outcome. Before prescribing any drug to human beings, it is necessary to have a clear picture of its uses, especially its safety, which is practically unknown in the case of medical cannabis.

En los últimos años, se ha observado un incremento significativo en el interés por la prescripción del cannabis medicinal. En el siguiente artículo, se informa acerca de la escasa base científica que avala la prescripción de estos compuestos en un listado amplio y diverso de patologías médicas. Se considera fundamental que cualquier sustancia que vaya a ser utilizada en humanos siga un protocolo de aprobación estricto y científico, que pueda desligarse de modas o de resultados individuales. Es necesario que, antes de la prescripción de una droga en personas, deba tenerse un panorama claro de cuáles son los usos del compuesto en cuestión, pero, sobre todo, de su seguridad, que es prácticamente desconocida en el cannabis medicinal.

Catatonia is not schizophrenia and it is treatable.

Catatonia is a cluster of motor features that appears in many recognized psychiatric illnesses, that according to the DSM-5 it is not linked as a subtype to schizophrenia anymore. The classic signs are mutism, a rigid posture, fixed staring, stereotypic movements, and stupor, which are all part of a broad psychopathology that may be found in affective, thought, neurological, toxic, metabolic and immunological disorders. Despite the many etiologies, catatonia may be a life-threatening condition with a specific treatment. Benzodiazepines are the first line therapeutic option for catatonia, being lorazepam the first-choice drug. Eighty percent of the patients are relieved by the use of barbiturates or benzodiazepines, while in those who fail, an improvement is achieved by electroconvulsive therapy (ECT). With more than 60years of use in catatonic patients, ECT has proven to be an effective and safe tool for the treatment of this frequent and sometimes forgotten syndrome.

Prevalencia de estrés, síndrome de desgaste profesional, ansiedad y depresión en médicos de un hospital universitario durante la pandemia de COVID-19 / Prevalence of stress, burnout syndrome, anxiety and depression among physicians of a teaching hospital during the COVID-19 pandemic

Introducción. Los trabajadores de la salud se encuentran sometidos a una gran tensión en el desarrollo de sus actividades, lo que genera alta frecuencia de estrés, desgaste laboral e impacto psicopatológico. La pandemia de COVID-19 podría provocar un incremento de estas entidades en los médicos. El objetivo fue describir la frecuencia de estrés, síndrome de desgaste profesional (burnout), ansiedad y depresión durante la pandemia, y analizar las asociaciones con distintas variables independientes. Métodos. Estudio observacional, transversal, realizado dos meses después del inicio de la cuarentena en Argentina. Se encuestó a médicos de especialidades clínicas, quirúrgicas, solo de emergencias, y a aquellos sin contacto directo con pacientes, mediante un cuestionario sociodemográfico y tres inventarios autoadministrados: Health Professions Stress Inventory, Maslach Burnout Inventory y la Escala de ansiedad y depresión hospitalaria. Resultados. La prevalencia de estrés fue del 93,7 % (IC95 %: 90,33-96,2), burnout 73,5 % (IC95 %: 68,2-78,4), ansiedad 44 % (IC95 %: 38,4-49,8) y depresión 21,9 % (IC95 %: 17,3-26,9). No se observó asociación entre la frecuencia y el tipo de especialidad realizada. La frecuencia de burnout, ansiedad y depresión fue significativamente mayor en los médicos residentes y en aquellos que trabajan en emergencias. Conclusiones. Los médicos residentes y quienes trabajan en emergencias en turnos de 24 horas mostraron porcentajes significativamente más altos de burnout, ansiedad y depresión, en comparación con médicos de planta y con aquellos en posiciones de liderazgo. Estos hallazgos pueden estar asociados con una mayor carga de trabajo y una menor experiencia. Es mandatorio tomar medidas preventivas y terapéuticas para preservar a quienes hacen frente a esta pandemia.

Introduction. Health care workers experience a tremendous strain while performing their activities, very frequently leading to stress, burnout syndrome, and psychopathological impact. The COVID-19 pandemic may cause physicians to suffer these effects even to a greater extent. Our objective was to describe the frequency of stress, burnout syndrome, anxiety, and depression during the pandemic, and analyze the associations with different independent outcome measures. Methods. Observational, cross-sectional study conducted 2 months after the lockdown was established in Argentina. Clinical specialists, surgeons, emergency physicians, and those with no direct contact with patients were surveyed using a sociodemographic questionnaire and 3 self-administered inventories: Health Professions Stress Inventory, Maslach Burnout Inventory, and Hospital Anxiety and Depression Scale. Results. The prevalence of stress was 93.7 % (95 % confidence interval [CI]: 90.33-96.2), burnout syndrome 73.5 % (95 % CI: 68.2-78.4), anxiety 44 % (95 % CI: 38.4-49.8), and depression 21.9 % (95 % CI: 17.3-26.9). No association was observed between the frequency and medical specialty. The frequency of burnout syndrome, anxiety, and depression was significantly higher among residents and physicians working in the emergency department. Conclusions. Residents and emergency physicians working 24-hour shifts showed significantly higher percentages of burnout syndrome, anxiety, and depression compared to staff and head physicians. These findings may be associated with a higher workload and less experience. It is compulsory to take preventive and therapeutic measures to protect those in the pandemic front line.